ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
63,892.36
1.15%
S&P 500
5,180.74
1.03%
Dow Jones
38,852.27
0.46%
US Dollar vs Yen
154.43
0.12%
Brent Oil
83.425
-0.06%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. XORTX Therapeutics Inc (XRTX)

  7. XORTX Therapeutics Inc (XRTX) ニュース

XRTX

XORTX Therapeutics (XRTX)

XORTX Therapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:XRTX
日付受信時刻ニュースソース見出しコード企業名
2024/05/0102 : 54GlobeNewswire Inc.XORTX Reprices Warrants Issued in Connection with Previous Private PlacementsNASDAQ:XRTXXORTX Therapeutics Inc
2024/04/2220 : 00GlobeNewswire Inc.XORTX Announces Publication of Key Research in ADPKDNASDAQ:XRTXXORTX Therapeutics Inc
2024/04/0820 : 30GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:XRTXXORTX Therapeutics Inc
2024/04/0820 : 00GlobeNewswire Inc.XORTX Announces Participation in Spring 2024 Investor ConferencesNASDAQ:XRTXXORTX Therapeutics Inc
2024/03/2718 : 00GlobeNewswire Inc.XORTX Announces New Clinical Advisory Board MemberNASDAQ:XRTXXORTX Therapeutics Inc
2024/03/1918 : 00GlobeNewswire Inc.XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical TrialNASDAQ:XRTXXORTX Therapeutics Inc
2024/03/1120 : 00GlobeNewswire Inc.XORTX Reprices Warrants Issued in Connection with Previous Private PlacementsNASDAQ:XRTXXORTX Therapeutics Inc
2024/03/0421 : 00GlobeNewswire Inc.XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
2024/02/1521 : 00GlobeNewswire Inc.XORTX Raises $2.5 Million Under Prospectus Supplement and Concurrent Private Placement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
2024/02/0210 : 46GlobeNewswire Inc.XORTX Files an Amended and Restated Prospectus Supplement for the Offering of UnitsNASDAQ:XRTXXORTX Therapeutics Inc
2024/01/1521 : 00GlobeNewswire Inc.XORTX Announces $2 Million Public OfferingNASDAQ:XRTXXORTX Therapeutics Inc
2024/01/0321 : 25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2024/01/0321 : 00GlobeNewswire Inc.XORTX Submits a New Patent for the Treatment of Chronic Kidney DiseaseNASDAQ:XRTXXORTX Therapeutics Inc
2024/01/0222 : 12Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2024/01/0221 : 00GlobeNewswire Inc.XORTX Welcomes New Member to the Board of DirectorsNASDAQ:XRTXXORTX Therapeutics Inc
2023/12/0106 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2023/11/3021 : 30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2023/11/3021 : 30GlobeNewswire Inc.XORTX Announces US ATM OfferingNASDAQ:XRTXXORTX Therapeutics Inc
2023/11/3011 : 57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:XRTXXORTX Therapeutics Inc
2023/11/2921 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2023/11/2921 : 00GlobeNewswire Inc.XORTX Meets Nasdaq Continued Listing RequirementsNASDAQ:XRTXXORTX Therapeutics Inc
2023/11/1321 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2023/11/1021 : 00GlobeNewswire Inc.XORTX Clarifies Timing for Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
2023/11/0907 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2023/11/0907 : 00GlobeNewswire Inc.XORTX Announces Share ConsolidationNASDAQ:XRTXXORTX Therapeutics Inc
2023/11/0220 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2023/11/0220 : 00GlobeNewswire Inc.XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2023NASDAQ:XRTXXORTX Therapeutics Inc
2023/10/2806 : 30GlobeNewswire Inc.XORTX Announces Results of Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
2023/10/2606 : 00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:XRTXXORTX Therapeutics Inc
2023/10/2606 : 00GlobeNewswire Inc.XORTX Announces Date for Rescheduled Special Meeting of ShareholdersNASDAQ:XRTXXORTX Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:XRTX

最近閲覧した銘柄

NYSE
CVX
Chevron
NYSE
DIS
Walt Disney
NYSE
KO
Coca Cola
SPI
SP500
S&P 500
NYSE
MRK
Merck
NYSE
AXP
American Express
COIN
SOLUSD
Solana
AMEX
XLE
Energy Select Sector SPDR
NASDAQ
NVDA
NVIDIA
USOTC
RHHBY
Roche (QX)
NYSE
XOM
Exxon Mobil
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
BAC
Bank of America
NYSE
MCD
McDonalds
NYSE
VZ
Verizon Communications
NASDAQ
AMZN
Amazon.com
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有